Diseases caused by altered specificity of a protein kinase for its allosteric activators

被引:0
|
作者
Cohen, Philip [1 ]
Snelling, Tom [1 ]
机构
[1] Univ Dundee, MRC Prot Phosphorylat & Ubiquitylat Unit, Dundee, Scotland
基金
英国惠康基金; 英国医学研究理事会;
关键词
NF-KAPPA-B; DEPENDENT KINASE; DISCOVERY; HEPTOSES; BINDING;
D O I
10.1016/j.tibs.2024.10.008
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Protein kinases regulate many intracellular processes, and their dysregulation causes cancers and other diseases. This review focuses on the atypical alpha-kinase 1 (ALPK1), which is activated in mammalian cells by nucleoside diphosphate heptoses (ADP-heptose, UDP-heptose, and CDP-heptose) produced by microbial pathogens but not by mammalian cells. Mutations in human ALPK1 cause ROSAH syndrome and spiradenoma, which result from an alteration in its specificity for nucleoside diphosphate heptoses, causing aberrant activation by mammalian nucleoside diphosphate sugars without microbial infection. These may be the first diseases caused by altered specificity of an enzyme for its allosteric activators and has suggested ways in which selective drugs could be developed to treat them without compromising the innate immune system.
引用
收藏
页码:61 / 70
页数:10
相关论文
共 50 条
  • [1] MODULATION OF THE SUBSTRATE-SPECIFICITY OF PURIFIED HUMAN PROTEIN-KINASE-C BY ITS ACTIVATORS
    HANSSON, A
    INGELMANSUNDBERG, M
    ACTA CHEMICA SCANDINAVICA SERIES B-ORGANIC CHEMISTRY AND BIOCHEMISTRY, 1987, 41 (03): : 174 - 179
  • [2] Peptide inhibitors and allosteric activators of allosteric activators of intraceilular protein-protein interactions as pharmaceuticals
    Mochly-Rosen, D.
    BIOPOLYMERS, 2007, 88 (04) : 526 - 526
  • [3] Mechanism of Allosteric Regulation of Substrate Specificity in Protein Kinase C
    Vaidehi, Nagarajan
    Song, Hyun Deok
    Devamani, Titu
    Sommese, Ruth
    Sivaramakrishnan, Sivaraj
    BIOPHYSICAL JOURNAL, 2017, 112 (03) : 496A - 496A
  • [4] Discovery and Development of Allosteric Pantothenate Kinase Activators
    Sharma, Lalit Kumar
    Subramanian, Chitra
    Yun, Mi-Kyung
    White, Stephen
    Jackowski, Suzanne
    Lee, Richard E.
    Rock, Charles O.
    FASEB JOURNAL, 2017, 31
  • [5] Isoform specificity of activators and inhibitors of protein kinase C gamma and delta
    Keenan, C
    Goode, N
    Pears, C
    FEBS LETTERS, 1997, 415 (01): : 101 - 108
  • [6] The active conformation of human glucokinase is not altered by allosteric activators
    Petit, Pierre
    Antoine, Mathias
    Ferry, Gilles
    Boutin, Jean A.
    Lagarde, Amandine
    Gluais, Laure
    Vincentelli, Renaud
    Vuillard, Laurent
    ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2011, 67 : 929 - 935
  • [7] Signal peptides are allosteric activators of the protein translocase
    Gouridis, Giorgos
    Karamanou, Spyridoula
    Gelis, Ioannis
    Kalodimos, Charalampos G.
    Economou, Anastassios
    NATURE, 2009, 462 (7271) : 363 - U132
  • [8] Signal peptides are allosteric activators of the protein translocase
    Giorgos Gouridis
    Spyridoula Karamanou
    Ioannis Gelis
    Charalampos G. Kalodimos
    Anastassios Economou
    Nature, 2009, 462 : 363 - 367
  • [9] Caged Activators of Artificial Allosteric Protein Biosensors
    Edwardraja, Selvakumar
    Guo, Zhong
    Whitfield, Jason
    Lantadilla, Ignacio Retamal
    Johnston, Wayne A.
    Walden, Patricia
    Vickers, Claudia E.
    Alexandrov, Kirill
    ACS SYNTHETIC BIOLOGY, 2020, 9 (06): : 1306 - 1314
  • [10] Structure and allosteric effects of low-molecular-weight activators on the protein kinase PDK1
    Valerie Hindie
    Adriana Stroba
    Hua Zhang
    Laura A Lopez-Garcia
    Leila Idrissova
    Stefan Zeuzem
    Daniel Hirschberg
    Francis Schaeffer
    Thomas J D Jørgensen
    Matthias Engel
    Pedro M Alzari
    Ricardo M Biondi
    Nature Chemical Biology, 2009, 5 : 758 - 764